| Brand | Active ingredient | Application holder | Expiry | Excl. |
|---|---|---|---|---|
| ABSORICA LD | ISOTRETINOIN | SUN PHARMACEUTICAL INDUSTRIES LTD | 29 May | - |
| ABSORICA LD | ISOTRETINOIN | SUN PHARMACEUTICAL INDUSTRIES LTD | 04 Aug | - |
| ACCRUFER | FERRIC MALTOL | SHIELD TX UK LTD | 06 Jan | NPP |
| ACCRUFER | FERRIC MALTOL | SHIELD TX UK LTD | 23 Oct | NPP |
| ADHANSIA XR | METHYLPHENIDATE HYDROCHLORIDE | KNOA PHARMA LLC | 30 Oct | - |
| ADRENALIN | EPINEPHRINE | PH HEALTH LTD | 13 Mar | - |
| AIRDUO DIGIHALER | FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 06 Apr | - |
| AIRDUO DIGIHALER | FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 14 Dec | - |
| AIRDUO RESPICLICK | FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 06 Apr | - |
| AKYNZEO | NETUPITANT; PALONOSETRON HYDROCHLORIDE | HELSINN HEALTHCARE SA | 25 Sept | - |
| ALECENSA | ALECTINIB HYDROCHLORIDE | HOFFMANN-LA ROCHE INC | 24 Apr | ODE-477 |
| ALUNBRIG | BRIGATINIB | TAKEDA PHARMACEUTICALS USA INC | 10 Nov | ODE-300 |
| ALYFTREK | DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM | VERTEX PHARMACEUTICALS INC | 14 Apr | ODE-536 |
| AMVUTTRA | VUTRISIRAN SODIUM | ALNYLAM PHARMACEUTICALS INC | 14 Aug | ODE-527 |
| APONVIE | APREPITANT | HERON THERAPEUTICS INC | 18 Sept | - |
| AQVESME | MITAPIVAT SULFATE | AGIOS PHARMACEUTICALS INC | 11 Apr | ODE-522 |
| ARAKODA | TAFENOQUINE SUCCINATE | 60 DEGREES PHARMACEUTICALS INC | 02 Dec | - |
| ARIKAYCE KIT | AMIKACIN SULFATE | INSMED INC | 15 May | GAIN |
| ARISTADA | ARIPIPRAZOLE LAUROXIL | ALKERMES INC | 19 Mar | - |
| ARISTADA INITIO KIT | ARIPIPRAZOLE LAUROXIL | ALKERMES INC | 17 Aug | - |
| ARISTADA INITIO KIT | ARIPIPRAZOLE LAUROXIL | ALKERMES INC | 08 Sept | - |
| ARMONAIR DIGIHALER | FLUTICASONE PROPIONATE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 14 Dec | - |
| AUGTYRO | REPOTRECTINIB | BRISTOL MYERS SQUIBB CO | 23 Jan | ODE-483 |
| AXUMIN | FLUCICLOVINE F-18 | BLUE EARTH DIAGNOSTICS LTD | 30 Dec | - |
| AZSTARYS | DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE | COMMAVE SUB LLC A WHOLLY OWNED SUB OF COLLEGIUM PHARMACEUTICAL INC | 07 May | NCE |
| BAFIERTAM | MONOMETHYL FUMARATE | BANNER LIFE SCIENCES LLC | 27 Feb | - |
| BALVERSA | ERDAFITINIB | JANSSEN BIOTECH INC | 26 Mar | I-930 |
| BALVERSA | ERDAFITINIB | JANSSEN BIOTECH INC | 18 Oct | I-930 |
| BIKTARVY | BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | GILEAD SCIENCES INC | 19 Jun | ODE-540 |
| BLUJEPA | GEPOTIDACIN MESYLATE | GLAXOSMITHKLINE LLC | 20 Aug | GAIN |
| BREXAFEMME | IBREXAFUNGERP CITRATE | GLAXOSMITHKLINE LLC | 19 Jan | GAIN |
| BRINSUPRI | BRENSOCATIB | INSMED INC | 21 Jan | NCE |
| BRINSUPRI | BRENSOCATIB | INSMED INC | 12 Mar | NCE |
| BUNAVAIL | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | BIODELIVERY SCIENCES INTERNATIONAL INC | 24 Apr | - |
| CALQUENCE | ACALABRUTINIB MALEATE | ASTRAZENECA UK LTD | 21 Jan | D-200 |
| CALQUENCE | ACALABRUTINIB | ASTRAZENECA UK LTD | 11 Aug | D-200 |
| CINVANTI | APREPITANT | HERON THERAPEUTICS INC | 18 Sept | - |
| COMBOGESIC IV | ACETAMINOPHEN; IBUPROFEN SODIUM | HIKMA PHARMACEUTICALS USA INC | 17 Jul | NP |
| COPIKTRA | DUVELISIB | SECURA BIO INC | 26 Apr | - |
| CRENESSITY | CRINECERFONT | NEUROCRINE BIOSCIENCES INC | 21 Jan | ODE-503 |
| CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | EUGIA PHARMA SPECIALITIES LTD | 26 Jun | - |
| CYTALUX | PAFOLACIANINE SODIUM | ON TARGET LABORATORIES INC | 29 Nov | ODE-390 |
| DAWNZERA (AUTOINJECTOR) | DONIDALORSEN SODIUM | IONIS PHARMACEUTICALS INC | 01 May | ODE-550 |
| DAYVIGO | LEMBOREXANT | EISAI INC | 21 Oct | M-293 |
| DEFINITY | PERFLUTREN | LANTHEUS MEDICAL IMAGING INC | 28 Dec | - |
| DEFINITY RT | PERFLUTREN | LANTHEUS MEDICAL IMAGING INC | 28 Dec | - |
| EKTERLY | SEBETRALSTAT | KALVISTA PHARMACEUTICALS LTD | 26 Nov | ODE-534 |
| EPIDIOLEX | CANNABIDIOL | JAZZ PHARMACEUTICALS RESEARCH UK LTD | 17 Jun | ODE-326 |
| EPIDIOLEX | CANNABIDIOL | JAZZ PHARMACEUTICALS RESEARCH UK LTD | 13 Oct | ODE-326 |
| ERLEADA | APALUTAMIDE | JANSSEN BIOTECH INC | 03 Dec | - |
| ERMEZA | LEVOTHYROXINE SODIUM | MYLAN PHARMACEUTICALS INC | 27 Feb | - |
| ESKATA | HYDROGEN PEROXIDE | ACLARIS THERAPEUTICS INC | 21 Apr | - |
| ESKATA | HYDROGEN PEROXIDE | ACLARIS THERAPEUTICS INC | 04 Jul | - |
| EVRYSDI | RISDIPLAM | GENENTECH INC | 11 May | ODE-400 |
| EVZIO | NALOXONE HYDROCHLORIDE | KALEO INC | 20 Mar | - |
| EVZIO (AUTOINJECTOR) | NALOXONE HYDROCHLORIDE | KALEO INC | 20 Mar | - |
| EXEM FOAM KIT | AIR POLYMER-TYPE A | GISKIT PHARMA BV | 04 May | - |
| EXKIVITY | MOBOCERTINIB SUCCINATE | TAKEDA PHARMACEUTICALS USA INC | 13 May | ODE-374 |
| FETROJA | CEFIDEROCOL SULFATE TOSYLATE | SHIONOGI INC | 03 Sept | GAIN |
| FIRVANQ KIT | VANCOMYCIN HYDROCHLORIDE | AZURITY PHARMACEUTICALS INC | 13 Mar | - |
| FRINDOVYX | CYCLOPHOSPHAMIDE | AVYXA HOLDINGS LLC | 13 Jul | - |
| FRINDOVYX | CYCLOPHOSPHAMIDE | AVYXA HOLDINGS LLC | 01 Dec | - |
| FRUZAQLA | FRUQUINTINIB | TAKEDA PHARMACEUTICALS USA INC | 07 Sept | NCE |
| GENOSYL | NITRIC OXIDE | VERO BIOTECH INC | 20 Oct | - |
| GOZELLIX | GALLIUM GA-68 GOZETOTIDE | TELIX INNOVATIONS SA | 28 Jul | - |
| HETLIOZ | TASIMELTEON | VANDA PHARMACEUTICALS INC | 12 Feb | ODE-330 |
| HETLIOZ | TASIMELTEON | VANDA PHARMACEUTICALS INC | 27 Jul | ODE-330 |
| HETLIOZ | TASIMELTEON | VANDA PHARMACEUTICALS INC | 29 Aug | ODE-330 |
| HETLIOZ LQ | TASIMELTEON | VANDA PHARMACEUTICALS INC | 12 Feb | ODE-329 |
| HETLIOZ LQ | TASIMELTEON | VANDA PHARMACEUTICALS INC | 27 Jul | ODE-329 |
| HETLIOZ LQ | TASIMELTEON | VANDA PHARMACEUTICALS INC | 29 Aug | ODE-329 |
| HYRNUO | SEVABERTINIB | BAYER HEALTHCARE PHARMACEUTICALS INC | 10 Oct | NCE |
| ILLUCCIX | GALLIUM GA-68 GOZETOTIDE | TELIX PHARMACEUTICALS US INC | 28 Jul | - |
| IMBRUVICA | IBRUTINIB | PHARMACYCLICS LLC | 24 Apr | PED |
| IMPOYZ | CLOBETASOL PROPIONATE | PRIMUS PHARMACEUTICALS INC | 11 Mar | - |
| INLYTA | AXITINIB | PF PRISM CV | 03 Feb | - |
| INLYTA | AXITINIB | PF PRISM CV | 03 Aug | - |
| INOMAX | NITRIC OXIDE | MALLINCKRODT PHARMACEUTICALS IRELAND LTD | 19 Feb | - |
| INOMAX | NITRIC OXIDE | MALLINCKRODT PHARMACEUTICALS IRELAND LTD | 19 Aug | - |
| ISTURISA | OSILODROSTAT PHOSPHATE | RECORDATI RARE DISEASES INC | 06 Jul | ODE-535 |
| ISTURISA | OSILODROSTAT PHOSPHATE | RECORDATI RARE DISEASES INC | 12 Oct | ODE-535 |
| JUBLIA | EFINACONAZOLE | BAUSCH HEALTH AMERICAS INC | 25 Apr | - |
| JYLAMVO | METHOTREXATE | SHORLA PHARMA LTD | 25 Oct | - |
| JYLAMVO | METHOTREXATE | SHORLA PHARMA LTD | 28 Oct | - |
| KAPSPARGO SPRINKLE | METOPROLOL SUCCINATE | SUN PHARMA INDUSTRIES LTD | 09 Jul | - |
| KENGREAL | CANGRELOR | CHIESI USA INC | 10 Jul | - |
| KERENDIA | FINERENONE | BAYER HEALTHCARE PHARMACEUTICALS INC | 29 Jul | I-970 |
| KIMYRSA | ORITAVANCIN DIPHOSPHATE | MELINTA THERAPEUTICS LLC | 16 Jul | - |
| KISQALI | RIBOCICLIB SUCCINATE | NOVARTIS PHARMACEUTICALS CORP | 07 Feb | PED |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | NOVARTIS PHARMACEUTICALS CORP | 07 Feb | PED |
| LAZCLUZE | LAZERTINIB MESYLATE | JANSSEN BIOTECH INC | 13 Oct | NCE |
| LENVIMA | LENVATINIB MESYLATE | EISAI INC | 26 Aug | PED |
| LICART | DICLOFENAC EPOLAMINE | IBSA INSTITUT BIOCHIMIQUE SA | 20 Feb | NPP |
| LIVDELZI | SELADELPAR LYSINE | GILEAD SCIENCES INC | 19 Mar | ODE-486 |
| LOKELMA | SODIUM ZIRCONIUM CYCLOSILICATE | ASTRAZENECA PHARMACEUTICALS LP | 14 Oct | - |
| LONHALA MAGNAIR KIT | GLYCOPYRROLATE | SUMITOMO PHARMA AMERICA INC | 14 Sept | - |
| MAVYRET | GLECAPREVIR; PIBRENTASVIR | ABBVIE INC | 08 May | PED |
| MAVYRET | GLECAPREVIR; PIBRENTASVIR | ABBVIE INC | 05 Jun | PED |
| MAVYRET | GLECAPREVIR; PIBRENTASVIR | ABBVIE INC | 08 Nov | PED |
| MAVYRET | GLECAPREVIR; PIBRENTASVIR | ABBVIE INC | 05 Dec | PED |
| MIEBO | PERFLUOROHEXYLOCTANE | BAUSCH AND LOMB INC | 01 Oct | NCE |
| NITYR | NITISINONE | CYCLE PHARMACEUTICALS LTD | 05 Jan | - |
| NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | NOREPINEPHRINE BITARTRATE | INFORLIFE SA | 26 Feb | - |
| OBREDON | GUAIFENESIN; HYDROCODONE BITARTRATE | SOVEREIGN PHARMACEUTICALS LLC | 13 Nov | - |
| OHTUVAYRE | ENSIFENTRINE | MERCK SHARP AND DOHME LLC | 15 Sept | NCE |
| OJEMDA | TOVORAFENIB | DAY ONE BIOPHARMACEUTICALS INC | 23 Jun | ODE-478 |
| OJJAARA | MOMELOTINIB DIHYDROCHLORIDE | GLAXOSMITHKLINE LLC | 03 Jan | ODE-441 |
| OJJAARA | MOMELOTINIB DIHYDROCHLORIDE | GLAXOSMITHKLINE LLC | 11 Jun | ODE-441 |
| OMLONTI | OMIDENEPAG ISOPROPYL | OCUVEX THERAPEUTICS INC | 08 Jan | NCE |
| OMLONTI | OMIDENEPAG ISOPROPYL | OCUVEX THERAPEUTICS INC | 10 Jun | NCE |
| ONPATTRO | PATISIRAN SODIUM | ALNYLAM PHARMACEUTICALS INC | 27 Aug | M-270 |
| OPFOLDA | MIGLUSTAT | AMICUS THERAPEUTICS US LLC | 30 Sept | NP |
| ORBACTIV | ORITAVANCIN DIPHOSPHATE | MELINTA THERAPEUTICS LLC | 16 Jul | - |
| ORLADEYO | BEROTRALSTAT DIHYDROCHLORIDE | BIOCRYST PHARMACEUTICALS INC | 09 Mar | PED |
| ORLADEYO | BEROTRALSTAT DIHYDROCHLORIDE | BIOCRYST PHARMACEUTICALS INC | 07 Apr | PED |
| ORLADEYO | BEROTRALSTAT DIHYDROCHLORIDE | BIOCRYST PHARMACEUTICALS INC | 09 Sept | PED |
| ORLADEYO | BEROTRALSTAT DIHYDROCHLORIDE | BIOCRYST PHARMACEUTICALS INC | 07 Oct | PED |
| OTIPRIO | CIPROFLOXACIN | ALK-ABELLO INC | 01 Jul | - |
| OXBRYTA | VOXELOTOR | GLOBAL BLOOD THERAPEUTICS INC | 06 Feb | ODE-394 |
| OXLUMO | LUMASIRAN SODIUM | ALNYLAM PHARMACEUTICALS INC | 14 Aug | ODE-415 |
| OXLUMO | LUMASIRAN SODIUM | ALNYLAM PHARMACEUTICALS INC | 09 Oct | ODE-415 |
| PEMAZYRE | PEMIGATINIB | INCYTE CORP | 30 Jan | ODE-404 |
| PEMETREXED | PEMETREXED DISODIUM | SHILPA MEDICARE LTD | 26 Mar | - |
| PEMFEXY | PEMETREXED | EAGLE PHARMACEUTICALS INC | 28 Oct | - |
| PLUVICTO | LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN | NOVARTIS PHARMACEUTICALS CORP | 12 Nov | I-965 |
| PONVORY | PONESIMOD | VANDA PHARMACEUTICALS INC | 10 Dec | NCE |
| PYRUKYND | MITAPIVAT SULFATE | AGIOS PHARMACEUTICALS INC | 11 Apr | ODE-392 |
| QALSODY | TOFERSEN | BIOGEN MA INC | 01 Apr | ODE-432 |
| QBRELIS | LISINOPRIL | AZURITY PHARMACEUTICALS INC | 06 Nov | - |
| QELBREE | VILOXAZINE HYDROCHLORIDE | SUPERNUS PHARMACEUTICALS INC | 02 Apr | NCE |
| QULIPTA | ATOGEPANT | ABBVIE INC | 30 Jan | NCE |
| QULIPTA | ATOGEPANT | ABBVIE INC | 28 Sept | NCE |
| REZLIDHIA | OLUTASIDENIB | RIGEL PHARMACEUTICALS INC | 18 Sept | ODE-413 |
| REZUROCK | BELUMOSUDIL MESYLATE | KADMON PHARMACEUTICALS LLC | 09 Apr | ODE-362 |
| RHOFADE | OXYMETAZOLINE HYDROCHLORIDE | MAYNE PHARMA LLC | 11 Jun | - |
| RIOMET ER | METFORMIN HYDROCHLORIDE | SUN PHARMACEUTICAL INDUSTRIES LTD | 01 May | - |
| RIVFLOZA | NEDOSIRAN SODIUM | NOVO NORDISK INC | 09 Oct | ODE-531 |
| RIVFLOZA | NEDOSIRAN SODIUM | NOVO NORDISK INC | 29 Oct | ODE-531 |
| ROZLYTREK | ENTRECTINIB | GENENTECH INC | 17 Feb | ODE-448 |
| ROZLYTREK | ENTRECTINIB | GENENTECH INC | 19 Feb | ODE-448 |
| RUBRACA | RUCAPARIB CAMSYLATE | PHARMAAND GMBH | 17 Aug | I-982 |
| SCEMBLIX | ASCIMINIB HYDROCHLORIDE | NOVARTIS PHARMACEUTICALS CORP | 29 Oct | ODE* |
| SOLOSEC | SECNIDAZOLE | EVOFEM INC | 04 Sept | GAIN |
| SOLOSEC | SECNIDAZOLE | EVOFEM INC | 16 Sept | GAIN |
| SOTYLIZE | SOTALOL HYDROCHLORIDE | AZURITY PHARMACEUTICALS INC | 31 Aug | - |
| SPINRAZA | NUSINERSEN SODIUM | BIOGEN INC | 11 Sept | - |
| SPRAVATO | ESKETAMINE HYDROCHLORIDE | JANSSEN PHARMACEUTICALS INC | 10 Sept | I-959 |
| SPY AGENT GREEN KIT | INDOCYANINE GREEN | NOVADAQ TECHNOLOGIES ULC | 04 Aug | I-911 |
| SUBLOCADE | BUPRENORPHINE | INDIVIOR INC | 06 Nov | M-314 |
| SYMDEKO (COPACKAGED) | IVACAFTOR; IVACAFTOR, TEZACAFTOR | VERTEX PHARMACEUTICALS INC | 14 Apr | ODE-335 |
| TABRECTA | CAPMATINIB HYDROCHLORIDE | NOVARTIS PHARMACEUTICAL CORP | 22 Jul | ODE-291 |
| TAGRISSO | OSIMERTINIB MESYLATE | ASTRAZENECA PHARMACEUTICALS LP | 02 Jan | ODE-337 |
| TAZVERIK | TAZEMETOSTAT HYDROBROMIDE | EPIZYME INC | 16 Oct | ODE-314 |
| TAZVERIK | TAZEMETOSTAT HYDROBROMIDE | EPIZYME INC | 19 Dec | ODE-314 |
| TECFIDERA | DIMETHYL FUMARATE | BIOGEN INC | 13 Mar | - |
| TECFIDERA | DIMETHYL FUMARATE | BIOGEN INC | 16 Nov | - |
| TIBSOVO | IVOSIDENIB | SERVIER PHARMACEUTICALS LLC | 13 Mar | ODE-447 |
| TRIKAFTA (COPACKAGED) | ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR | VERTEX PHARMACEUTICALS INC | 06 Oct | ODE-543 |
| TYRVAYA | VARENICLINE TARTRATE | OYSTER POINT PHARMA INC | 19 Oct | - |
| TYVASO DPI | TREPROSTINIL | UNITED THERAPEUTICS CORP | 01 Apr | - |
| TYZAVAN | VANCOMYCIN HYDROCHLORIDE | HIKMA PHARMACEUTICALS USA INC | 06 Nov | - |
| UBRELVY | UBROGEPANT | ABBVIE INC | 30 Jan | - |
| UKONIQ | UMBRALISIB TOSYLATE | TG THERAPEUTICS INC | 26 May | NCE |
| VANCOMYCIN | VANCOMYCIN | HIKMA PHARMACEUTICALS USA INC | 06 Nov | - |
| VASOSTRICT | VASOPRESSIN | PH HEALTH LTD | 30 Jan | - |
| VEKLURY | REMDESIVIR | GILEAD SCIENCES INC | 29 Oct | PED |
| VELPHORO | FERRIC OXYHYDROXIDE | VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE | 26 May | PED |
| VIEKIRA XR | DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR | ABBVIE INC | 02 Jan | - |
| VITRAKVI | LAROTRECTINIB SULFATE | BAYER HEALTHCARE PHARMACEUTICALS INC | 16 Nov | - |
| VIVLODEX | MELOXICAM | ICEUTICA OPERATIONS LLC | 31 Mar | - |
| VIZZ | ACECLIDINE HYDROCHLORIDE | LENZ THERAPEUTICS INC | 18 Jun | NCE |
| VORANIGO | VORASIDENIB | SERVIER PHARMACEUTICALS LLC | 04 Dec | ODE-491 |
| VOXZOGO | VOSORITIDE | BIOMARIN PHARMACEUTICAL INC | 11 Jun | ODE-449 |
| VOYDEYA | DANICOPAN | ALEXION PHARMACEUTICALS INC | 25 Feb | ODE-476 |
| VYALEV | FOSCARBIDOPA; FOSLEVODOPA | ABBVIE INC | 21 Oct | NP |
| VYKAT XR | DIAZOXIDE CHOLINE | SOLENO THERAPEUTICS INC | 12 Nov | ODE-532 |
| VYNDAMAX | TAFAMIDIS | FOLDRX PHARMACEUTICALS LLC A WHOLLY OWNED SUB OF PFIZER INC | 31 Aug | ODE-237 |
| XACDURO (COPACKAGED) | DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM | ENTASIS THERAPEUTICS INC | 17 Nov | GAIN |
| XENOVIEW | XENON XE-129 HYPERPOLARIZED | POLAREAN INC | 20 Feb | NCE |
| XENOVIEW | XENON XE-129 HYPERPOLARIZED | POLAREAN INC | 29 Dec | NCE |
| XPOVIO | SELINEXOR | KARYOPHARM THERAPEUTICS INC | 14 Aug | ODE* |
| XYOSTED (AUTOINJECTOR) | TESTOSTERONE ENANTHATE | ANTARES PHARMA INC | 19 Feb | - |
| XYOSTED (AUTOINJECTOR) | TESTOSTERONE ENANTHATE | ANTARES PHARMA INC | 25 Feb | - |
| XYOSTED (AUTOINJECTOR) | TESTOSTERONE ENANTHATE | ANTARES PHARMA INC | 07 Aug | - |
| XYOSTED (AUTOINJECTOR) | TESTOSTERONE ENANTHATE | ANTARES PHARMA INC | 18 Oct | - |
| XYOSTED (AUTOINJECTOR) | TESTOSTERONE ENANTHATE | ANTARES PHARMA INC | 19 Nov | - |
| YCANTH | CANTHARIDIN | VERRICA PHARMACEUTICALS INC | 28 May | NCE |
| ZEGALOGUE | DASIGLUCAGON HYDROCHLORIDE | ZEALAND PHARMA US INC | 22 Mar | NPP |
| ZEGALOGUE (AUTOINJECTOR) | DASIGLUCAGON HYDROCHLORIDE | ZEALAND PHARMA US INC | 22 Mar | NPP |
| ZELSUVMI | BERDAZIMER SODIUM | LNHC INC | 10 Jul | NCE |
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | CUBIST PHARMACEUTICALS LLC | 09 Mar | PED |
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | CUBIST PHARMACEUTICALS LLC | 14 Aug | PED |
| ZILBRYSQ | ZILUCOPLAN SODIUM | UCB INC | 12 Jun | ODE-446 |
| ZINGO | LIDOCAINE HYDROCHLORIDE | POWDER PHARMACEUTICALS INC | 27 Apr | - |
| ZINGO | LIDOCAINE HYDROCHLORIDE | POWDER PHARMACEUTICALS INC | 28 Sept | - |
| ZITUVIO | SITAGLIPTIN | ZYDUS LIFESCIENCES GLOBAL FZE | 25 Feb | - |
| ZYNRELEF KIT | BUPIVACAINE; MELOXICAM | HERON THERAPEUTICS INC | 20 Apr | I-933 |
Provenance
Source: FDA Orange Book patent and exclusivity files. Rows carrying an exclusivity code have a separate regulatory exclusivity that can outlast the patent shown. Patent expiry alone does not determine when a generic can launch: paediatric extensions, 30-month stays and settlement agreements frequently move the effective date. Delisted patents are excluded.